Navigation Links
Mayor Julian 'Jolly' Reseueollo Dialysis Center Officially Opens Doors With Support From Bridge of Life - DaVita Medical Missions
Date:7/24/2009

TACOMA, Wash., July 24 /PRNewswire-FirstCall/ -- Bridge of Life - DaVita Medical Missions(TM), a 501(c)(3) non-profit organization that focuses on bringing life-saving dialysis to developing countries, officially opened its doors to the city of San Carlos community on July 21 to a crowd of 200 area residents. With the colors, sounds and dances of the Pangasinan province surrounding the event, onlookers watched as Governor Amado T. Espino cut the ribbon on the new facility and thanked Ginny Mello, Director of the Bridge of Life - DaVita Medical Missions, and the rest of the American medical team for bringing life-saving treatment to local San Carlos residents.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

"We cannot say in words how lucky we are for having partners like the Bridge of Life - DaVita Medical Missions," Governor Espino said. "On behalf of the people of Pangasinan, we kindly extend our thanks to all of you for your wonderful partnership and service to our residents."

The Bridge of Life's July activities in San Carlos have been extensive, with volunteers holding a Renal Awareness Camp on July 11, designed to increase knowledge surrounding personal health needs related to kidney disease. Over 20 doctors and nurses attended, with 75 local residents receiving kidney screening. During the screening, the medical team found that many residents had hypertension, one of the main causes of kidney disease in the Filipino population. The second Renal Awareness Camp is scheduled for July 25.

The first patient to receive kidney dialysis at the new Philippines facility was Virginia Rosario, a 57-year-old ER nurse in San Carlos. Virginia was forced to stop working on the emergency room floor of the local government hospital because of
'/>"/>

SOURCE DaVita Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
2. Mayors Express Frustration Over President Bushs Veto to SCHIP Legislation
3. Mayors Office Declares October 13 as First Metastatic Breast Cancer Awareness Day for New York City
4. Mayor Antonio Villaraigosa Partners With AltaMed Health Services to Launch City of Los Angeles HIV Testing Initiative
5. The United States Conference of Mayors Observes World AIDS Day
6. Delray Beach Mayor Commemorates Diagnostic Centers of America (DCA) $2 Million Purchase from Siemens to Become Only Medical Facility in South Florida with Worlds Most Advanced Cardiac Scanner.
7. Congresswoman Norton, Mayor Fenty, Verizon and the Washington Wizards Join the Test for Life Campaign to Encourage HIV Screenings in DC
8. AMN Healthcare Chairman Devotes Full Attention to Mayoral Race
9. Mayor Hula Hoops at City Council Meeting
10. Mayor Bloomberg Declares March 6, 2008 World Glaucoma Day in New York City
11. Mayor Bill White Proclaims World Day of Design in Houston
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine Technology:Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases 2Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 2Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 3Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 4Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 5Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 6